News


All News

Researchers examining Medicare prescribing patterns of oral anticoagulants and non-insulin diabetes drugs have found that pharmaceutical marketing to physicians involving payments was associated with physicians being more likely to prescribe those marketed drugs.

With the recent discoveries of immunologic pathways leading to psoriasis, clinicians are likely to discount older general immunosuppressive agents in favor of newer larger molecules like biologics that provide better targeted therapy.

Many dermatologists are approached by parties interested in acquiring a practice. Knowing ahead of time what questions you should ask-and how to answer their questions-can turn a simple inquiry by them into a wealth of information for you.

The costs of popular drugs-even generics-in dermatology are soaring, leaving patients scrambling for coverage or financial assistance and dermatologists spending precious hours on prior authorizations, drug appeals and reviews. In this first of a five-part series, experts and patients help define the problem.

The largest-ever vismodegib study in advanced basal cell carcinoma, the STEVIE study, confirms pivotal study findings in a real-world setting, helping dermatologists to provide a complete palette of skin cancer treatments.

New information could eventually help identify a high-risk population before they get cancer - even prevent skin cancer’s onset.

First do no Mohs harm

An expert advises evaluating each patient’s surrounding circumstances when determining whether Mohs surgery is indicated.

New technology aims to create a new paradigm in the medical care for survivors of burns and traumatic scars. Jill Waibel shares her experience using lasers for trauma rehabilitation. New non-profit hopes to help injured military heroes and first responders.

It’s quite a sacrifice to close your practice for a mission trip. One doctor describes her experience and offers resources for other dermatologists interested in volunteering.

Promising treatments under investigation for vitiligo include afamelanotide, prostaglandin analogues and JAK inhibitors. But don't overlook established treatments such as phototherapy and steroid mini-pulses, an expert says.

Beyond the plaque

There’s good evidence to suggest dermatologists who assess psoriasis patients should look beyond the plaques on the skin and consider not just the increased risk to the joints, but also the heart, mind and more.